Clinicopathological Significance and Potential Drug Target of RUNX3 in Non-Small Cell Lung Cancer: A meta-Analysis

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s76358
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited